Cargando…

5597349 VITAMIN C AND VITAMIN K2 AS RISK FACTORS FOR OSTEOPOROSIS IN CHILDREN WITH B- THALASSEMIA

Detalles Bibliográficos
Autores principales:	Sherief, l.M.S., Ahmed, A.S.A., Baraka, A.M.B., Zakaria, M.M.Z., Rquwaydir, M.R.Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	e-Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112574/ http://dx.doi.org/10.1097/01.HS9.0000928528.16555.41

Ejemplares similares

5588571 DYSLIPIDEMIA IN TRANSFUSION-DEPENDENT-THALASSEMIA PATIENTS AND ITS CORRELATION WITH SERUM VITAMIN D LEVEL
por: El-Ghamrawy, M., et al.
Publicado: (2023)

Osteoporosis in Iraqi patients with thalassemia
por: AL Jadir, Salim M, et al.
Publicado: (2012)

Vitamin K and Osteoporosis
por: Fusaro, Maria, et al.
Publicado: (2020)

5613374 ASSOCIATION BETWEEN GENOTYPE AND DISEASE COMPLICATIONS IN EGYPTIAN PATIENTS WITH BETA THALASSEMIA
por: Hassan, T.H., et al.
Publicado: (2023)

5613398 A DRUG REPOSITIONING PROJECT FOR Β-THALASSEMIA: SIROLIMUS AND CINCHONA ALKALOIDS
por: Michele Lipucci Di Paola, M.L.P., et al.
Publicado: (2023)

5558131 GENETICS OF IRANIAN ALPHA THALASSEMIA PATIENTS; COMPREHENSIVE ORIGINAL STUDY
por: Khosravi, A., et al.
Publicado: (2023)

5613312 PLASMATIC MICROPARTICLES AS POTENTIAL BIOMARKERS IN THE PREVENTIVE DIAGNOSIS OF BETA THALASSEMIA
por: Chebbi, M., et al.
Publicado: (2023)

The Benefits of vitamin E on liver function and the hemopoietic System in thalassemia Patients
por: Hashemian, Z, et al.
Publicado: (2012)

5574716 PROBLEMS AND STRATEGIES OF BLOOD TRANSFUSION IN THALASSEMIA DURING COVID-19 PANDEMIC IN INDONESIA
por: Rahmartani, L.D.R., et al.
Publicado: (2023)

Vitamin K(2) Therapy for Postmenopausal Osteoporosis
por: Iwamoto, Jun
Publicado: (2014)

5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT -THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER
por: Maria Vousvouki, M.V., et al.
Publicado: (2023)

5613417 CO-TREATMENT OF ERYTHROID CELLS ISOLATED FROM Β039-THALASSEMIA PATIENTS WITH CRISPR-CAS9 GENE EDITING AND FETAL HEMOGLOBIN INDUCTION
por: Lipucci di Paola, M.L.P., et al.
Publicado: (2023)

5610178 SURVIVAL AND COMPLICATIONS IN PATIENTS WITH HEMOGLOBINOPATHIES: THE EXPERIENCE OF A SINGLE DEPARTMENT OF THALASSEMIA AND SICKLE DISEASE
por: Xydaki, X.A., et al.
Publicado: (2023)

5588005 IMPACT OF COVID-19 PANDEMIC TO PRE-TRANSFUSION HEMOGLOBIN LEVEL AND FREQUENCY OF TRANSFUSION IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS IN INDONESIA
por: Dewi, M.K.D., et al.
Publicado: (2023)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

Geographic variation in the reversal of vitamin K antagonist-associated coagulopathy
por: Neal, M, et al.
Publicado: (2008)

Influence of Vitamin K on Bone Mineral Density and Osteoporosis
por: Elshaikh, Abeer O, et al.
Publicado: (2020)

The Anti-Inflammatory Role of Vitamin E in Prevention of Osteoporosis
por: Nazrun, A. S., et al.
Publicado: (2012)

67 Double impact: hypophosphatemic rickets and vitamin D intoxication
por: Boutrid, N, et al.
Publicado: (2022)

Vitamin K
por: Shea, M Kyla, et al.
Publicado: (2021)

Bone Mineral Density and Vitamin D Receptor Genetic Variants in Egyptian Children with Beta Thalassemia Major on Vitamin D Supplementation
por: Abbassy, Hadeer A, et al.
Publicado: (2019)

Vitamin D Status in Thalassemia Major: an Update
por: Soliman, Ashraf, et al.
Publicado: (2013)

Effects of Vitamin K(2) on the Development of Osteopenia in Rats as the Models of Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2006)

Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt
por: Fahim, Fahim M., et al.
Publicado: (2013)

Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review
por: Sankar, M J, et al.
Publicado: (2016)

Optimal Use of Vitamin D When Treating Osteoporosis
por: van den Bergh, Joop P. W., et al.
Publicado: (2010)

The use of calcium and vitamin D in the management of osteoporosis
por: Sunyecz, John A
Publicado: (2008)

Combined treatment of vitamin K and teriparatide on bone metabolism and biomechanics in rats with osteoporosis
por: Huang, Youqing
Publicado: (2018)

Vitamin K Deficiency Bleeding Presenting as Nodular Purpura in Infancy: A Rare and Life-Threatening Entity
por: Gahalaut, Pratik, et al.
Publicado: (2013)

Vitamin D Binding Protein Genotype and Osteoporosis
por: Fang, Yue, et al.
Publicado: (2009)

Vitamin K Metabolism and Vitamin K-Dependent Proteins
por: Levinson, Barry L.
Publicado: (1980)

Genetic influence of vitamin D receptor gene polymorphisms on osteoporosis risk
por: Banjabi, Abeer A., et al.
Publicado: (2020)

S111: BRAIN PERFUSION CHANGES IN BETA-THALASSEMIA
por: Manara, R, et al.
Publicado: (2022)

5613391 SUBCLINICAL NEPHROTOXICITY IN PATIENTS WITH BETA-THALASSEMIA: ROLE OF URINARY KIDNEY INJURY MOLECULE
por: Zakaria, M., et al.
Publicado: (2023)

The effect of pharmacological treatment in combination with vitamin K on healing in an experimental rat model of osteoporosis
por: Öz, İhsan, et al.
Publicado: (2023)

Vitamin K Status in Chronic Kidney Disease
por: McCabe, Kristin M., et al.
Publicado: (2013)

Vitamin K
Publicado: (1940)

Concentration of major vitamins in critically ill patients
por: Hayami, H, et al.
Publicado: (2012)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Vitamin D and osteoporosis in chronic kidney disease
por: Lips, Paul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2rh5ucn4j2lce7lcjg1vqtbsn6